Trials / Completed
CompletedNCT07351331
Intratissue Electrolysis (EPI) is Effective in Deactivating Myofascial Trigger Points (MTrPs). (EPIEMG)
The Effectiveness of Intratissue Percutaneous Electrolysis in the Shortening of the Flexor Hallucis Brevis Caused by Myofascial Pain Syndrome. A Pre-post Study.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Camilo Jose Cela University · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Invasive physiotherapy techniques, such as Intratissue Percutaneous Electroly-sis (IPE), have numerous beneficial effects depending on the pathology being treated, in-cluding the deactivation of myofascial trigger points (MTP) caused by myofascial pain syndrome (MPS). The objectives are (1) evaluate the effectiveness of low intesity IPE treatment com-pared to DN on the shortening of FHB in patients with MPS, in 4 and 12 weeks evaluation, (2) assess the distribution of plantar pressures after the interventions and (3) evaluate the modification of FHB activation following the interventions.
Detailed description
Patients are divided into two intervention groups (IPE; n=18) and (DN; n=22). Before the intervention, variables of mean and maximum pressure are measured in all patients using a pressure platform, and neuromuscular activity is assessed through surface electromy-ography (sEMG). These measures are repeated at 4- and 12-weeks post-intervention. The results show efficacy in both techniques, with significant differences at both 4 weeks and 12 weeks in favor of the IPE group, both in plantar pressure distribution and muscular activity. The first measurement (week of November 25, 2024) is considered the baseline measurement since the subjects had not been previously intervened. Therefore, the measurement is first performed using the pressure platform and sEMG, followed by the intervention of DN or IPE based on the group to which the subjects were previously as-signed. At week 4 from the first measurement (week of December 23, 2024), the second data collection is conducted, using the same procedure as in the first measurement. At week 12 from the initial measurement (week of February 17, 2025), the third data collection takes place using the same procedure as the previous two, with the difference that in this final measurement there will be no intervention of DN or IPE.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Intratissue Percutaneous Electroly | Three interventions were performed, the first in the initial week, after pressure and sEMG measurements, the second in week 4, and the third in week 12. |
| OTHER | dry needling | Three interventions were performed, the first in the initial week, after pressure and sEMG measurements, the second in week 4, and the third in week 12. |
Timeline
- Start date
- 2024-11-15
- Primary completion
- 2025-02-28
- Completion
- 2025-04-24
- First posted
- 2026-01-20
- Last updated
- 2026-01-20
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT07351331. Inclusion in this directory is not an endorsement.